Sponsor:
LB Pharmaceuticals Inc.
Code:
NCT07369154
Conditions
Schizophrenia
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
LB-102
Brief summary:
Conditions
Schizophrenia
Study ID
NCT07369154
Start date
Apr 23, 2026
Status verified date
Jul, 2026
Completion date
Apr, 2029
Anticipated
Primary completion date
Dec, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Enrollment
900 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
other: LB-102
Interventions
LB-102
Primary outcome measure
Central contacts
Locations
Chandler Clinical Trials
Recruiting
Chandler, Arizona, United States, 85224
Contacts
Pillar Clinical Research
Recruiting
Bentonville, Arkansas, United States, 72712
Contacts
Principal Investigator:
Fayz Hudefi, MD
Pillar Clinical Research
Recruiting
Little Rock, Arkansas, United States, 72204
Contacts
Principal Investigator:
Leslie Smith, MD
Woodland International Research Group
Recruiting
Little Rock, Arkansas, United States, 72211
Contacts
Advanced Research Center
Recruiting
Anaheim, California, United States, 92805
Contacts
Synapse Clinical Trials
Recruiting
Cerritos, California, United States, 90703
Contacts
ProScience Research Group
Recruiting
Culver City, California, United States, 90230
Contacts
CenExel
Recruiting
Culver City, California, United States, 92845
Contacts
Synergy San Diego
Recruiting
San Diego, California, United States, 92064
Contacts
CenExel
Recruiting
Hollywood, Florida, United States, 33024
Contacts
Principal Investigator:
Edwin Gomez, MD
Segal Trials
Recruiting
Miami Lakes, Florida, United States, 33063
Contacts
Health Synergy Clinical Research
Recruiting
West Palm Beach, Florida, United States, 33407
Contacts
CenExel
Recruiting
Atlanta, Georgia, United States, 30331
Contacts
Accelerated Clinical Trial
Recruiting
Snellville, Georgia, United States, 30078
Contacts
Pillar Clinical Research
Recruiting
Chicago, Illinois, United States, 60641
Contacts
Betty Davis
bdavis@pillarhc.comPrincipal Investigator:
Roueen Rafeyan, MD
CenExel Gaithersburg
Recruiting
Gaithersburg, Maryland, United States, 20877
Contacts
Arch Clinical Trials
Recruiting
St Louis, Missouri, United States, 63141
Contacts
Redbird Research
Recruiting
Las Vegas, Nevada, United States, 89119
Contacts
Neuro-Behavioral Clinical Research
Recruiting
New York, New York, United States, 11516
Contacts
Neuro-Behavioral Clinical Research
Recruiting
Canton, Ohio, United States, 44720
Contacts
Nate Fontes
330-493-1118Adams Clinical
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Isabel Bear
ibear@adamsclinical.comAdams Clinical
Recruiting
DeSoto, Texas, United States, 75115
Contacts
Pillar Clinical Research
Recruiting
Richardson, Texas, United States, 75080
Contacts
Sponsor
LB Pharmaceuticals Inc.
Last update posted
Jul 27, 2026
Last verified
Jul, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by LB Pharmaceuticals Inc. on 2026-07-27.